The following discussion of the results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements and notes thereto included in Item 1 of this part. This report, including the information incorporated by reference, contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. The use of any of the words "believe," "expect," "anticipate," "plan," "estimate," and similar expressions are intended to identify such statements. Forward-looking statements include statements concerning our possible or assumed future results. The actual results that we achieve may differ materially from those discussed in such forward-looking statements due to the risks and uncertainties described in the Risk Factors section of this report, in Management's Discussion and Analysis of Financial Condition and Results of Operations, and in other sections of this report, as well as in our annual report on Form 10-K. We undertake no obligation to update any forward-looking statements.





Overview



Corporate History and Structure

We were incorporated on June 28, 2010 in the State of Nevada under the name "Island Radio, Inc." and changed our name to "China Herb Group Holdings Corporation" effective July 17, 2012. On December 9, 2019, the Company changed its corporate name to "Tengjun Biotechnology Corp."

On June 27, 2012, Eric R. Boyer and Nina Edstrom (collectively, the "Sellers"), who were then the major shareholders of the Company, entered into a Share Purchase Agreement with Chin Yung Kong, Qiuping Lu and Fumin Feng (collectively, the "Purchasers"), pursuant to which the Sellers sold to the Purchasers an aggregate 4,000,000 shares of the common stock of the Company, which represented approximately 93% of the then total issued and outstanding stock of the Company, for a total purchase price of $159,970 (the "Change in Control"). As result of this share purchase transaction, Chin Yung Kong, Qiuping Lu and Fumin Feng became the controlling shareholders of the Company.

Acquisitions/Business Combinations

On December 23, 2021, the Company entered into a Share Purchase/Exchange Agreement (the "Share Exchange Agreement") with Tengjunxiang Biotechnology Ltd. (the "Target"), a Cayman Islands corporation, and the Target's eleven shareholders (the "Selling Shareholders"): Min Xing Biotechnolgy Ltd, Pastoral Technology Co., Ltd., Shu Zhilin Trading Co., Ltd., Teng Rui Xiang Bio-Tech Ltd., Aihua Trading Co., Ltd, Rock Climbing Technology, Langtaosha Trading Co., Ltd., Min Cheng Biotechnology Ltd, Kangfan Technology Co., Ltd., Chaorong Technology Co., Ltd., and Shengrui Biotechnology Co., Ltd. In accordance with the Share Exchange Agreement, on December 23, 2021, the Selling Shareholders collectively sold and transferred 500,000,000 ordinary shares of the Target, constituting one hundred percent (100%) of the issued and outstanding share capital of the Target, to the Company in exchange for 19,285,714 shares of Company's common stock, par value $0.001 per share (the "Tengjun Shares"), at an agreed price of $0.19 per share of the Company's common stock (the "Common Stock") for a total valuation of $3,675,000 of the Target.

In connection with the acquisition of the Target pursuant to the Share Exchange Agreement, the Company is entering into the Chinese tea and water purifier business through its newly acquired subsidiary the Target Company, which owns four corporate entities: (i) Tengjunxiang Biotechnology HK Limited ("Tengjun HK"), a company formed in Hong Kong and wholly owned by the Target, (ii) Shandong Minfu Biotechnology Co., Ltd. ("WFOE"), a wholly foreign owned entity formed under the laws of China and wholly owned by Tengjun HK, (iii) Shandong Tengjunxiang Biotechnology Co., Ltd. ("Shangdong Tengjunxiang"), a company formed under the laws of China and 94.95% owned by WFOE, and (iv) Jinxiang County Kanglong Water Purification Equipment Co. Ltd. ("Kanglong"), a company formed under the laws of China and wholly-owned subsidiary of Shandong Tengjunxiang. The parties to this Agreement closed the transaction contemplated therein on December 23, 2021.

The Target was incorporated on July 19, 2021 under the laws of the Cayman Islands. The authorized capital stock of the Target is 500,000,000 ordinary shares, all of which were issued and outstanding prior to the closing of the Acquisition. Shangdong Tengjunxiang, our operating company, was formed on June 27, 2014, under the laws of China. Promptly after the Closing, the Target shall update the shareholder registration of the Target to effect the Share Exchange Agreement. The Share Exchange Agreement was signed and agreed by and among all of the shareholders and/or beneficial owners of the Target, the Target and the Company.





                                       17




As a result of the consummation of the Acquisition on December 23, 2021 as discussed above, the Target became a wholly-owned subsidiary of the Company and the business of the Target became the business of the Company.

The diagram below illustrates our corporate structure following the Acquisition:





                               [[Image Removed]]


We have limited operations and are currently generating limited revenues from our business operations. Our independent registered public accounting firm has issued a going concern opinion for the year ended December 31, 2021. This means that our auditors believe there is substantial doubt that we can continue as an on-going business for the next 12 months. Accordingly, we may have to raise additional cash from various sources, including operations, controlling shareholders' investments and debt and equity financing from third party investors.





                                       18





Results of Operations



Results of Operations - Three Months Ended March 31, 2022 Compared to Three Months Ended March 31, 2021.

The following table sets forth information from our statements of comprehensive income for the three months ended March 31, 2022 and 2021:





                                  Three Months Ended
                                       March 31,                         Change
                                  2022            2021          (Amount)        (Percent)
Sales revenue                 $  4,284,114     $        -     $  4,284,114               * %
Cost of Goods Sold                (370,064 )            -         (370,064 )             * %
Gross Profit                     3,914,050              -        3,914,050               * %
Operating Expenses              (3,588,312 )     (161,126 )     (3,427,186 )         2,127 %
Operating Income (Loss)            325,738       (161,126 )        486,864            (302 )%
Interest Income (Expense)               24         (4,973 )          4,997            (100 )%
Income Tax Provision               (92,955 )            -          (92,955 )             * %
Net Income (Loss)                  232,807       (166,099 )        398,906            (240 )%
Comprehensive Income (loss)   $    223,369     $ (159,502 )   $    382,871            (240 )%




Revenues


We generated $4,284,114 and $0 in revenues for the three months ended March 31, 2022 and 2021, respectively. The Company did not generate any revenue during the three months ended March 31, 2021 due to the impact of COVID-19.

The following is the sales breakdown by segment during the three months ended March 31, 2022 and 2021:





                         For the three months ended
                                  March 31,
                         2022                    2021

Dandelion teas $ 3,463,678 81 % $ - - % Water purifier 820,436 19 % - - % Total

$ 4,284,114       100 %   $     -         - %




During the three months ended March 31, 2022, sales of Dandelion teas generated $3,463,678 in revenue, constituting approximately 81% of the total revenue for that quarter, and sales of water purifiers generated $820,436 in revenue, representing approximately 19% of the total revenue for such quarter.





Cost of Goods Sold


Our cost of goods sold was $370,064 and $0 for the three months ended March 31, 2022 and 2021, respectively. During the three months ended March 31, 2022, cost of sales of dandelion teas was $273,847, constituting approximately 74% of the total cost of goods sold, and cost of sales of water purifiers was $96,217, representing approximately 26% of the total cost of goods sold. The Company did not incur any cost in the three months ended March 31, 2021 because there were no sales during the first quarter of 2021.





Gross Margin


The following table presents gross margin by segment for three months ended March 31, 2022 and 2021:





                       For the three months ended
                                March 31,
                          2022                  2021

Dandelion teas $ 3,189,831 81 % $ - - % Water purifier 724,419 19 % - - % Total

$   3,914,050       100 %   $ -       - %




The gross profit as a percentage of net revenue for the Dandelion teas was 92% for the three months ended March 31, 2022. The gross profit as a percentage of net revenue for water purifiers was approximately 88% for the three months ended March 31, 2022.





                                       19




Selling and Marketing Expenses

Our selling and marketing expenses primarily consist of sales commission, advertising and product promotion expenses. Our selling and marketing expenses were $3,357,973 for the three months ended March 31, 2022 as compared to $3,459 for the three months ended March 31, 2021. Our total selling and marketing expenses increased by $3,354,514 or 96979% during the three months ended March 31, 2022, compared to the same period in 2021. Such increase in selling and marketing expenses was mainly due to the significant increase in sales commission.

General and administrative expenses

Our general and administrative expenses primarily consist of payroll and benefit costs for corporate employees, legal, consulting, professional expenses, rental expenses and other corporate overhead costs.

The general and administrative expenses was $230,339 for the three months ended March 31, 2022 as compared to $157,667 for the three months ended March 31, 2021. Our general and administrative expenses increased by $72,672 or 46% during the three months ended March 31, 2022, compared to the same period in 2021. Such increase in general and administrative expenses was mainly due to the increase in legal, accounting, printing, and stock transfer agent fees that were associated with the Company's merger and acquisition activities and SEC filings.





Interest income (expense)


Interest income (expense) was $24 for the three months ended March 31, 2022 as compared to $(4,973) for the three months ended March 31, 2021. Our total interest expense decreased by $(4,997) or 100% during the three months ended March 31, 2022, compared to the same period in 2021. The decrease in interest expense was primarily due to the repayment of short-term bank loan on March 17, 2021.





Net Income (Loss)



Our net income was $232,807 for the three months ended March 31, 2022 as compared to net loss of $166,099 for the three months ended March 31, 2021, increased by $398,906 or 240% as a result of the above factors.

Foreign Currency Translation Loss

We had $9,438 in foreign currency translation loss during the three months ended March 31, 2022 as compared to $6,597 in foreign currency translation gain during the three months ended March 31, 2021, reflecting a change of $16,035 or 243%. Such increase in foreign currency translation loss was primarily caused by the currency exchange rate fluctuation.

Liquidity and Capital Resources





Working Capital



                                                                         Change
                              March 31,       December 31,
                                2022              2021          (Amount)      (Percent)
Current Assets              $   5,277,371     $   4,628,531       634,840             14 %
Current Liabilities         $  16,755,289     $  16,316,116       439,713              3 %
Working Capital (deficit)   $ (11,477,918 )   $ (11,687,585 )     209,667             (2 )%



Our working capital deficit was $11,477,918 as of March 31, 2022 as compared to $11,687,585 as of December 31, 2021, a decrease of $209,667 or 2%. The decrease in working capital deficiency is primarily due to the increase in cash and cash equivalents during the three months ended March 31, 2022.





                                       20




Cash Flow from Operating Activities

Our net cash provided by operating activities were $1,260,939 for the three months ended March 31, 2022 as compared to $108,185 of net cash used for operating activities the three months ended March 31, 2021, reflecting an increase of $1,369,124 or 1266%. The increase was primarily due to the increased net income, decrease in inventories, prepaid taxes, and increase in taxes payable during the three months ended March 31, 2022 compared to the three months ended March 31, 2021.

Cash Flow from Investing Activities

Our net cash used in investing activities was $48,473 for the three months ended March 31, 2022 as compared to that of $186,176 for the three months ended March 31, 2021, reflecting a decrease of $137,703 or 74%. The decrease was primarily due to the decrease in payment for construction in progress, and the increase in payment for equipment during the three months ended March 31, 2022 as compared to those items in the three months ended March 31, 2021.

Cash Flow from Financing Activities

Our net cash provided by financing activities were $190,716 for the three months ended March 31, 2022 as compared to that of $298,984 for the three months ended March 31, 2021, representing a decrease of $108,268 or 36%. The increase was primarily due to the decreased cash inflow from loans from related parties during the three months ended March 31, 2022.

Off-Balance Sheet Arrangements

As of March 31, 2022, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

Critical Accounting Policies and Estimates

We prepare our financial statements in conformity with Generally Accepted Accounting Principles ("GAAP") of the United States, which requires management to make certain estimates and apply judgments. We base our estimates and judgments on historical experience, current trends and other factors that management believes to be important at the time the financial statements are prepared. On a regular basis, we review our accounting policies and how they are applied and disclosed in our financial statements.

While we believe that the historical experience, current trends and other factors considered support the preparation of our financial statements in conformity with GAAP, actual results could differ from our estimates and such differences could be material.





Inventories


Our inventories primarily consist of dandelion teas and water purifiers. Inventories are valued at the lower of cost (determined on a weighted average basis) and net realizable value. Inventories consist of raw materials, goods in process, and finished goods. We review our inventories regularly for possible obsolete goods and establishes reserves when determined necessary. As of March 31, 2022 and December 31, 2021, the allowance for obsolete inventories was $0 and $0, respectively.





                                       21





Construction in Progress



Construction in progress represents direct costs of construction, interest and design fees incurred. No interest was capitalized for the three months ended March 31, 2022 and 2021. Capitalization of these costs ceases and the construction in progress is transferred to property, plant, and equipment when substantially all the activities necessary to prepare the assets for their intended use are completed. No depreciation is recognized until it is completed and ready for intended use. Construction in progress as of March 31, 2022 and December 31, 2021 was $8,818,289 and $8,726,299, respectively.





Revenue Recognition


The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers. To determine the revenue to be recognized, the Company applies the following five-step model:





  ? identify arrangements with customers;

  ? identify performance obligations;

  ? determine transaction price;

  ? allocate transaction price to the separate performance obligations in the
    arrangement, if more than one exists; and

  ? recognize revenue as performance obligations are satisfied.



The Company generates revenues mainly from sales of packaged dandelion teas and water purifiers. Revenue from the sales of goods is recognized when the control over the promised goods is transferred to customers.

Cash payments received or due from customers before revenue recognized are recorded as advances from customers. The advance from customers is recognized as revenue when the Company's performance obligation is completed.





Related parties


The Company follows ASC 850, "Related Party Disclosures," for the identification of related parties and disclosure of related party transactions. Parties are related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant influence, such as a family member or relative, shareholder, or a related corporation.

Recent Accounting Pronouncements

See Note 3 to our unaudited consolidated financial statements for the three months ending March 31, 2022 and 2021.





                                       22

© Edgar Online, source Glimpses